| 产品编号 | CFN91736 | |
| CAS编号 | 3387-36-8 | |
| 分子式 = 分子量 | C9H13N2O9P = 324.18 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 尿苷酸二钠盐 | CFN91736 | 3387-36-8 | 10mg | QQ客服:3257982914 |
| 尿苷酸二钠盐 | CFN91736 | 3387-36-8 | 20mg | QQ客服:3257982914 |
| 尿苷酸二钠盐 | CFN91736 | 3387-36-8 | 50mg | QQ客服:3257982914 |
| 尿苷酸二钠盐 | CFN91736 | 3387-36-8 | 100mg | QQ客服:3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | 5'-UMP disodium salt is component used for RNA synthesis.It has been used to study the effect of nucleotides on growth of specific intestinal bacteria. IC50 & Target: Human Endogenous Metabolite |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.0847 mL | 15.4235 mL | 30.8471 mL | 61.6941 mL | 77.1177 mL |
| 5 mM | 0.6169 mL | 3.0847 mL | 6.1694 mL | 12.3388 mL | 15.4235 mL |
| 10 mM | 0.3085 mL | 1.5424 mL | 3.0847 mL | 6.1694 mL | 7.7118 mL |
| 50 mM | 0.0617 mL | 0.3085 mL | 0.6169 mL | 1.2339 mL | 1.5424 mL |
| 100 mM | 0.0308 mL | 0.1542 mL | 0.3085 mL | 0.6169 mL | 0.7712 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 达帕菲尼; Dabrafenib | CFN60005 | 1195765-45-7 | C23H20F3N5O2S2 = 519.6 | 5mg | QQ客服:2159513211 |
| Calystegine B2; Calystegine B2 | CFN00161 | 127414-85-1 | C7H13NO4 = 175.18 | 5mg | QQ客服:2159513211 |
| 5,7,4’-三-O-甲基儿茶精; 5,7,4'-Tri-O-methylcatechin | CFN96042 | 105330-59-4 | C18H20O6 = 332.4 | 5mg | QQ客服:1413575084 |
| 3,5-O-二咖啡酰基奎宁酸甲酯; 3,5-Di-O-caffeoylquinic acid methyl ester | CFN90857 | 159934-13-1 | C26H26O12 = 530.5 | 5mg | QQ客服:2159513211 |